Bavarian Nordic A/S announced the appointment of Henrik Juuel to the position of Executive Vice President and Chief Financial Officer. Mr. Juuel is currently the CFO of Orexo AB, a fully integrated specialty pharmaceutical company listed on the asdaq Stockholm exchange, a role he has held since 2013. He plans to join avarian Nordic in the fourth quarter of 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.7 DKK | -0.57% |
|
-4.18% | -12.26% |
Jun. 18 | Bavarian Nordic Wraps Up US FDA's Biologics License Application for Chikungunya Vaccine Candidate | MT |
Jun. 13 | High-risk health workers can get routine Ebola vaccine, Gavi says | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.26% | 1.74B | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic Appoints Henrik Juuel as Chief Financial Officer and Executive Vice President